Back to Nova Southeastern University
Nova Southeastern University has a variety of technologies that are ready for commercialization. We are seeking external collaborators who can work with us to help these technologies fulfill their commercial potential and make a positive social impact.
We invite you to browse through this list of available technologies and reach out to us if any of them suit your commercial interests.
Browse Our Available Technologies
Method to Detect Ferromagnetic Objects Submerged in Water
A More Accurate Detection System
Novel Vaccine for Human Immunodeficiency Virus
Developing Immunogens Protective Against HIV
Limbus Segment Tracking to Quantify the Ocular Range of Motion
Accurately Track a Wider Range of Eye Movements
Novel Method for Treating Rheumatoid Arthritis
A Potential First-in-Class Therapeutic for RA
Diagnostic Methods for Chronic Fatigue Syndrome and Other Neuroimmune Disorders
Developing an Accurate, Quantitative Test for Complex Diseases
Methods for Treating Heart Failure and Other Cardiac Diseases
A Potential Therapeutic Intervention for Heart Failure
Method of Delivering Personalized Healthcare Information Based on Levels of Health Literacy
Tailored Medical Information Leads to Better Outcomes
System for Reducing Adverse Health Events in Assisting Living Facilities
Quicker, Easier Access to Medical Assistance
Method for Detecting Somatic Gene Mutations and Associating Them with Complex Multifactorial Diseases
Detecting Mutations for Complex Conditions
Novel Therapy for Metastatic Melanoma
Targeted Therapy That is More Effective Against Cancer Cells
Digital Mentoring and Career Guidance System to Facilitate Entry of Minorities in Health Care Professions
Mentoring Students Who Wish to Pursue a Career in Health Care
Regulation of Nuclear Excision Repair by MicroRNA for Treatment of Breast Cancer
Clinical Efficiency and Better Outcomes
Anti-VEGF Small Molecules for the Treatment of Solid Tumors
Destroying Tumors by Constraining Blood Supply
Immunotherapy with Oncolytic Virus and its Modulation by Use of Statins
More Efficient and Less Toxic Combination Therapy
Computational Pipeline and Method for Predicting Clinical Intervention Strategies for Complex Diseases
A More Accurate Prediction of Clinical Intervention
Genetically Modified Natural Killer Cells for Immunotherapy Against Melanoma
Targeting Tumor-Associated Antigens or Melanoma-Associated Antigens
Anti-VEGF Small Molecule for Treating Glioblastoma
Treating GBM with Poor Prognosis
Novel Antiepileptic Compounds
Antiseizure EfficacyContact
Gary Margules, Sc.D. | Vice President of Research and Technology Transfer | margules@nova.edu
Junko Kazumi, Ph.D. | Director of Technology Transfer | jkazumi@nova.edu | (954) 262-8554
Arunodoy Sur, Ph.D. | Technology Licensing Officer | asur@nova.edu | (954) 262-1022